Four cases on the most recent diabetes standards of care updates are discussed in this course, including semaglutide dosing, and treating diabetes with associated ASCVD and heart failure. Connect your learning to practice with these quick 15-minute cases for a total of one hour of CE.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Utilize a specific patient medical history, medications, laboratory results, and adherence matters to optimize diabetes therapy.
2. Apply the 2023 Diabetes guidelines to a patient with diabetes and ASCVD.
3. Apply the 2023 Diabetes guidelines to a patient with diabetes and heart failure.
4. Recommend type 2 diabetes treatment using the 2023 ADA pharmacologic approach.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Associate Director of Experiential EducationProfessor of Pharmacy Practice
Midwestern University College of Pharmacy – Downers Grove

Dr. Susan Cornell is an advisory board member for Bayer and Sanofi and an advisory board member and speaker’s bureau member for Novo Nordisk. All relevant financial relationships have been mitigated. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: March 1, 2023
Planned Expiration Date: March 1, 2026

Copyright 2023, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

RV1-10.23/EXP